Kimlun Corporation Berhad (KLSE:KIMLUN)

Checkpoint Therapeutics Ratios and Metrics

Market cap in millions MYR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	421	424	276	272	286	316
Market Cap Growth	-9.09%	53.85%	1.30%	-4.94%	-9.50%	-25.54%
Enterprise Value	1,119	954	647	540	608	658
Last Close Price	1.19	1.18	0.76	0.74	0.77	0.84
PE Ratio	5.54	8.28	39.07	-	-	39.61
Forward PE	6.61	11.42	9.82	6.67	6.97	9.38
PS Ratio	0.29	0.35	0.32	0.36	0.41	0.40
PB Ratio	0.52	0.54	0.37	0.38	0.39	0.43
P/TBV Ratio	0.53	0.56	0.39	0.38	0.40	0.44
P/FCF Ratio	-	-	4.90	8.35	2.57	43.18
P/OCF Ratio	-	-	3.09	5.04	2.44	24.08
PEG Ratio	0.75	0.30	0.30	0.30	0.30	0.30
EV/Sales Ratio	0.77	0.79	0.76	0.71	0.88	0.83
EV/EBITDA Ratio	6.64	7.87	12.13	12.46	11.62	9.32
EV/EBIT Ratio	8.49	10.21	20.39	56.12	46.23	21.46
EV/FCF Ratio	-10.00	-	11.50	16.57	5.46	89.91
Debt / Equity Ratio	0.90	0.88	0.57	0.44	0.45	0.57
Debt / EBITDA Ratio	4.36	5.55	7.50	6.84	5.91	5.65
Debt / FCF Ratio	-	-	7.51	9.73	2.94	57.14
Asset Turnover	0.76	0.67	0.60	0.58	0.49	0.53
Inventory Turnover	3.58	3.47	3.35	3.27	3.40	3.43
Quick Ratio	1.05	0.99	1.25	1.71	1.72	1.47
Current Ratio	1.39	1.42	1.74	2.36	2.14	1.82
Return on Equity (ROE)	9.71%	6.65%	0.94%	-1.00%	-0.10%	1.09%
Return on Assets (ROA)	4.24%	3.24%	1.40%	0.46%	0.59%	1.27%
Return on Capital (ROIC)	5.82%	4.41%	1.80%	0.57%	0.74%	1.67%
Return on Capital Employed (ROCE)	12.00%	8.70%	3.40%	1.10%	1.50%	3.50%
Earnings Yield	18.05%	12.08%	2.56%	-2.66%	-0.21%	2.53%
FCF Yield	-26.60%	-28.71%	20.43%	11.97%	38.91%	2.32%
Dividend Yield	1.56%	1.70%	1.31%	1.35%	1.30%	1.19%
Payout Ratio	4.65%	6.90%	50.09%	-	-	140.43%
Buyback Yield / Dilution	-0.01%	-0.01%	-	-	-3.67%	-1.68%
Total Shareholder Return	1.56%	1.69%	1.31%	1.35%	-2.37%	-0.48%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.